NCT01285089View on ClinicalTrials.gov

Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Acquired Bleeding DisorderAcquired Haemophilia
Interventions
DRUG

activated recombinant human factor VII

Data collection of the use of activated recombinant human factor VII observed through real-world treatment practices

Trial Locations (1)

92932

Paris La Défense Cedex

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY